Zobrazeno 1 - 10
of 24
pro vyhledávání: '"S. A. Korovkin"'
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 16, Iss 2, Pp 90-95 (2018)
The present article submits the results of work on the isolation and study of biological properties of bacteriophages, active against Klebsiella, Echerichia, Proteus, Pseudomonas, Staphylococcus. It also shows the results of the study such as: lytic
Externí odkaz:
https://doaj.org/article/b3cf8d4fb71d4b23a4523c757007995e
Autor:
I. S. Barulina, L. V. Sayapina, N. P. Baidalova, I. I. Khoreva, I. S. Mescheryakova, M. I. Kormilitsyna, S. A. Korovkin
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 1(99), Pp 64-66 (2009)
Analyzed were the results of specific safety control of the live tularemia dry vaccine used for tularemia prophylaxis. During the period of 1997-2006 this index was shown to be unstable. Specific safety of the vaccine is one of the main parameters of
Externí odkaz:
https://doaj.org/article/22e83bf9490547c8ad3a7deaf52c2d84
Publikováno v:
Russian Clinical Laboratory Diagnostics. 65:244-250
The study is devoted to the study of the antimicrobial activity of the antioxidant dioxidin and the complex dioxin-containing preparation Nosolin-ultra, nasal drops against planktonic and biofilm cultures of pathogens of ENT infections, the dynamics
Autor:
S. Y.U. Korovkin, A. D. Savinova
Publikováno v:
Психология. Журнал Высшей школы экономики. 16:164-180
Executive functions could play an important role in insight problem solving, however their character, content, and pattern of dynamics may significantly differ from the role of executive functions in non-insight problems. We employed a dual-task para
Publikováno v:
Klinicheskaia laboratornaia diagnostika. 65(4)
The study is devoted to the study of the antimicrobial activity of the antioxidant dioxidin and the complex dioxin-containing preparation Nosolin-ultra, nasal drops against planktonic and biofilm cultures of pathogens of ENT infections, the dynamics
Autor:
A. V. Semchenko, S. V. Sheremet’ev, O. V. Borisova, D. V. Lonshakov, A. V. Katlinskii, S. A. Korovkin, E. M. Belosludtseva
Publikováno v:
Pharmaceutical Chemistry Journal. 50:788-793
A method for the preparation of pharmacologically active conjugates of interferon α-2b with poly(ethylene glycol)s that absorbed in the visible spectral range was proposed. New covalent conjugates of linear poly(ethylene glycol)s with interferon α-
Autor:
E. M. Belosludtseva, D. V. Lonshakov, A. V. Semchenko, S. V. Sheremet’ev, S. A. Korovkin, A. V. Katlinskij
Publikováno v:
RSC Advances. 5:42903-42909
As the majority of reagents commonly used for protein pegylation have certain disadvantages concerning their reactivity, stability, convenience and selectivity of pegylation reaction, etc., the search for new pegylation reagents is of current interes
Autor:
S. A. Korovkin, I. S. Mescheryakova, I. I. Khoreva, L. V. Sayapina, I. S. Barulina, M. I. Kormilitsyna, N. P. Baidalova
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 1(99), Pp 64-66 (2009)
Analyzed were the results of specific safety control of the live tularemia dry vaccine used for tularemia prophylaxis. During the period of 1997-2006 this index was shown to be unstable. Specific safety of the vaccine is one of the main parameters of
Autor:
M K, Erofeeva, S Ia, Mel'nikov, A V, Semchenko, S A, Korovkin, I Iu, Nikonorov, V L, Maksakova, E M, Voĭtsekhovskaia, E S, Erman, V V, Gonchar, V K, Pozdeev, V P, Drinevskiĭ
Publikováno v:
Zhurnal mikrobiologii, epidemiologii i immunobiologii. (2)
Assessment of reactogenicity, safety and immunogenicity after single intramuscular immunization of children with Grifor vaccine.Reactogenicity, safety, and immunogenicity of Grifor vaccine compared with Vaxigrip vaccine was evaluated during phase III
Autor:
N A, Mazurkova, N N, Ryndiuk, L N, Shishkina, V A, Ternovoĭ, Iu V, Tumanov, L E, Bulychev, M O, Skarnovich, A S, Kabanov, S G, Panchenko, R P, Aleĭnikov, T N, Il'ina, V I, Kuzubov, S Ia, Mel'nikov, A N, Mironov, S A, Korovkin, A N, Sergeev, I G, Drozdov
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk. (3)
Results of phase II of a clinical trial of the influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2) are presented. The vaccine was developed based on strain /17/Duck/Potsdam/86/92 H5N2 [17/H5] - reassortant of two viruses, /Leningr